Document is current
Any future updates will be listed below
-
Authors
Rasooly, Danielle https://orcid.org/0000-0001-7715-1809
Giambartolomei, Claudia https://orcid.org/0000-0003-2786-1225
Peloso, Gina M. https://orcid.org/0000-0002-5355-8636
Dashti, Hesam
Ferolito, Brian R.
Golden, Daniel
Horimoto, Andrea R. V. R.
Pietzner, Maik https://orcid.org/0000-0003-3437-9963
Farber-Eger, Eric H. https://orcid.org/0000-0003-0281-3796
Wells, Quinn Stanton
Bini, Giorgio
Proietti, Gabriele
Tartaglia, Gian Gaetano
Kosik, Nicole M.
Wilson, Peter W. F.
Phillips, Lawrence S. https://orcid.org/0000-0002-6542-8046
Munroe, Patricia B. https://orcid.org/0000-0002-4176-2947
Petersen, Steffen E. https://orcid.org/0000-0003-4622-5160
Cho, Kelly
Gaziano, J. Michael
Leach, Andrew R. https://orcid.org/0000-0001-8178-0253
,
Whittaker, John
Langenberg, Claudia
Aung, Nay
Sun, Yan V. https://orcid.org/0000-0002-2838-1824
Pereira, Alexandre C.
Casas, Juan P.
Joseph, Jacob https://orcid.org/0000-0002-7279-4896
- License Information
-
More Information
Article History
Received: 13 June 2024
Accepted: 7 January 2025
First Online: 6 February 2025
Competing interests
: S.E.P. provides consultancy to Circle Cardiovascular Imaging, Inc. J.W. holds membership of scientific advisory boards/consultancy for Relation Therapeutics and Silence Therapeutics and ownership of GlaxoSmithKline shares. J.P.C. is employed full-time by the Novartis Institute of Biomedical Interest (his major contributions to this project were while employed at the VA Boston Healthcare System). The remaining authors declare no competing interests.
